ALLO vs FAST · rev $22.0K vs P/E 43, rev $7.55B
Allogene Therapeutics Inc (ALLO) versus Fastenal Company (FAST) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Fastenal Company (FAST) is a industrial distribution company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported FAST revenue for 2024-12-31 was $7.55B. Net income was $1.15B. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
ALLO currently screens at market cap $258.1M. FAST currently screens at market cap $49.48B and trailing P/E 43.1.
Not investment advice. Open the ALLO and FAST stock pages for the full models.
Not investment advice.